《Current Opinion In Lipidology》雜志的最新年發文量為37篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在生化與分子生物學領域的學術影響力。
該刊聚焦于醫學-生化與分子生物學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Current Opinion In Lipidology 雜志發文統計
文章名稱引用次數
- HDL from an Alzheimer's disease perspective20
- Sex differences in metabolism and cardiometabolic disorders19
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism19
- Classical and alternative roles for autophagy in lipid metabolism18
- RNA-targeted therapeutics for lipid disorders14
- Polygenic influences on dyslipidemias14
- New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk14
- New insights in the multiple roles of bile acids and their signaling pathways in metabolic control13
- The lysophosphatidic acid acyltransferases (acylglycerophosphate acyltransferases) family: one reaction, five enzymes, many roles12
- Metabolism: The road to inflammation and atherosclerosis11
國家/地區發文量
- USA80
- Canada36
- Netherlands25
- GERMANY (FED REP GER)16
- Australia15
- England12
- France10
- Italy7
- Scotland7
- Switzerland5
